China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multi-Omics Study of Guillain-Barre Syndrome Based on Multimodal Magnetic Resonance Imaging and Biofluid Biomarkers'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135663
Registration Time: 2026/11/01
Type: Observational study
Primary Sponsor: The Second Hospital of Anhui Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=312185
Published by HT Digital Content Services with permission from Health Daily Digest....